Evidence map›Paper›PMID 25748325›Full record

ArticleThe Journal of infectious diseases2015

Lung Mucosa Lining Fluid Modification of Mycobacterium tuberculosis to Reprogram Human Neutrophil Killing Mechanisms.

Jesús Arcos, Lauren E Diangelo, Julia M Scordo, Smitha J Sasindran, Juan I Moliva, Joanne Turner, Jordi B Torrelles

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Challenges in Developing a Controlled Human Tuberculosis Challenge Model.Current topics in microbiology and immunology · 2024
    Review
  6. Exposure ofFrontiers in tuberculosis · 2024
    Article
  7. International journal of molecular sciences · 2023
    Review
  8. Tuberculosis in an Aging World.Pathogens (Basel, Switzerland) · 2022
    Review
  9. Host- and Age-Dependent Transcriptional Changes inInternational journal of molecular sciences · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. Evolution of Drug-ResistantFrontiers in microbiology · 2021
    Review
  14. Review
  15. Host defense mechanisms against Mycobacterium tuberculosis.Cellular and molecular life sciences : CMLS · 2020
    Review
  16. Article
  17. Article
  18. Underestimated Manipulative Roles ofFrontiers in immunology · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jesús ArcosDepartment of Microbial Infection and Immunity.
Lauren E DiangeloDepartment of Microbial Infection and Immunity.
Julia M ScordoDepartment of Microbial Infection and Immunity.
Smitha J SasindranDepartment of Microbial Infection and Immunity.
Juan I MolivaDepartment of Microbial Infection and Immunity.
Joanne TurnerDepartment of Microbial Infection and Immunity Center for Microbial Interface Biology, College of Medicine, The Ohio State University, Columbus.
Jordi B TorrellesDepartment of Microbial Infection and Immunity Center for Microbial Interface Biology, College of Medicine, The Ohio State University, Columbus.
Interface (United States) · US

Funding

Integrative Training in Biomedical SystemsT32GM068412 · NIGMS · OHIO STATE UNIVERSITY · PI PARVIN, JEFFREY D · 2005 to 2020
$2.4M
Function of human lung mucosal hydrolases during M. tuberculosis infectionR01AI093570 · NIAID · OHIO STATE UNIVERSITY · PI TORRELLES, JORDI B · 2012 to 2015
$1.6M
Remodeling of the M. tuberculosis cell wall by the host microenvironmentR00AI073856 · NIAID · OHIO STATE UNIVERSITY · PI TORRELLES, JORDI B · 2009 to 2010
$561k
Remodeling of the M. tuberculosis cell wall by the host microenvironmentK99AI073856 · NIAID · OHIO STATE UNIVERSITY · PI TORRELLES, JORDI B · 2008 to 2008
$90k
NIAID NIH HHS AI093570-S1NIAID NIH HHS K99 AI073856NIAID NIH HHS K99/R00-AI073856NIAID NIH HHS R00 AI073856NIAID NIH HHS R01 AI093570NIAID NIH HHS R01-AI093570NIGMS NIH HHS T32 GM068412NIGMS NIH HHS T32-GM-068412
6 · The paper itself

Abstract

We have shown that human alveolar lining fluid (ALF) contains homeostatic hydrolases capable of altering the Mycobacterium tuberculosis cell wall and subsequently its interaction with human macrophages. Neutrophils are also an integral part of the host immune response to M. tuberculosis infection. Here we show that the human lung mucosa influences M. tuberculosis interaction with neutrophils, enhancing the intracellular killing of ALF-exposed M. tuberculosis and up-regulating the expression of tumor necrosis factor and interleukin 8. In contrast, ALF-exposed M. tuberculosis does not induce neutrophil apoptosis or necrosis, degranulation, or release of extracellular traps, and it decreases the oxidative response. These results suggest an important role for the human alveolar mucosa: increasing the innate capacity of the neutrophil to recognize and kill M. tuberculosis by favoring the use of intracellular mechanisms, while at the same time limiting neutrophil extracellular inflammatory responses to minimize their associated tissue damage.

Indexed as

ApoptosisBacteriological TechniquesBody FluidsCells, CulturedGene Expression RegulationHumansLungMycobacterium tuberculosisNeutrophilsRespiratory MucosaTumor Necrosis Factor-alphaTumor Necrosis Factor-alphaalveolar lining fluidinnate immunitylung surfactantneutrophiltuberculosis

Identifiers

PMID25748325
PMCPMC4548464
OpenAlexW2011838261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.